Oncolytics Biotech(R) Inc. Receives Approval from Belgium FAMHP to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers

Jun 01, 2010, 07:30 ET from Oncolytics Biotech Inc.

$countyNameToPathMap.put("sp